Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
15.15
-0.23 (-1.50%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Q32 Bio Employees
Q32 Bio had 22 employees as of March 31, 2026. The number of employees decreased by 7 or -24.14% compared to the same quarter last year.
Employees
22
Change
-7
Growth
-24.14%
Revenue / Employee
$2,442,591
Profits / Employee
$1,511,045
Market Cap
256.89M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 22 | -7 | -24.14% | 22 | 0 |
| Dec 31, 2025 | 24 | -19 | -44.19% | 24 | 0 |
| Sep 30, 2025 | 26 | -17 | -39.53% | 26 | 0 |
| Jun 30, 2025 | 28 | -15 | -34.88% | 27 | 1 |
| Mar 31, 2025 | 29 | -10 | -25.64% | 28 | 1 |
| Dec 31, 2024 | 43 | 6 | 16.22% | 42 | 1 |
| Sep 30, 2024 | 43 | 8 | 22.86% | 42 | 1 |
| Jun 30, 2024 | 43 | 8 | 22.86% | 41 | 2 |
| Mar 31, 2024 | 39 | - | - | 39 | 0 |
| Dec 31, 2023 | 37 | - | - | 37 | 0 |
| Sep 30, 2023 | 35 | - | - | 35 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Niagen Bioscience | 117 |
| SAB Biotherapeutics | 86 |
| Agenus | 81 |
| Lineage Cell Therapeutics | 77 |
| InflaRx | 65 |
| Fulcrum Therapeutics | 55 |
| Opus Genetics | 28 |
QTTB News
- 8 days ago - Q32 Bio files to sell 6.88M shares of common stock for holders - TheFly
- 8 days ago - Q32 Bio Registration statement: Registration filing - Filings
- 11 days ago - Q32 Bio 6.03M share secondary priced at $18.25 - TheFly
- 11 days ago - Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants - PRNewsWire
- 12 days ago - Q32 Bio announces $200M common stock offering - TheFly
- 12 days ago - Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - PRNewsWire
- 12 days ago - Q32 Bio price target raised to $36 from $14 at Mizuho - TheFly
- 12 days ago - Why Q32 Bio investors should take profits in the stock after 81% rally - Invezz